cardiovascular-disease-risk

Documents about cardiovascular-disease-risk

• Traditional and Non-traditional Cardiovascular Risk Factors in the Chronic Dialysis Population at Chris Hani Baragwanath Academic Hospital and Sebokeng Provincial Hospital#410646WIReDSpace
• Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study#355242PLOS
• Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study#316773Spiral
• Genomic Determinants and Shared Genetic Pathways of Periodontal Disease#864719ClinicalTrials.gov
• Effect of Vitamin D3 Supplementation on Cardiometabolic Risk#901256ClinicalTrials.gov
• Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)#901561ClinicalTrials.gov
• Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer#898198ClinicalTrials.gov
• Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity#901850ClinicalTrials.gov
• Review of breast arterial calcifications for cardiovascular disease risk prediction.#266967NCBI PubMed Central
• Federated Deep Learning for Privacy-Preserving Cardiovascular Disease Risk Prediction#353054arXiv CS
• Association Between Healthy Eating Patterns and Risk of Cardiovascular Disease#383838CiNii
• Hostility, Depression, Social Environment and CHD Risk#828939ClinicalTrials.gov
• Lipids, Inflammation, and CV Risk in RA#898568ClinicalTrials.gov
• A Study of Evacetrapib in High-Risk Vascular Disease#917029ClinicalTrials.gov
• Sex-Specific Patterns of Left Ventricular Remodeling Using Regional Wall Thickness Data and Their Associations with Cardiovascular Disease Risk#414295bioRxiv / medRxiv
• Reducing Total Cardiovascular Risk in an Urban Community#831202ClinicalTrials.gov
• Cardiovascular Health and Texting Messaging (CHAT) Study#1010458ClinicalTrials.gov
• General Cardiovascular Risk Profile for Use in Primary Care#6542OpenAlex
• Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors#841682ClinicalTrials.gov
• Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community#848204ClinicalTrials.gov
• Association of intraoperative pulse pressure drop and minimum mean arterial pressure with postoperative length of stay: A stratified reanalysis of published data by age and sex#236527PLOS
• Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk.#225064Repisalud
• Survival analysis of time to amputation following diabetic foot ulcer diagnosis among Indonesians#285437PLOS
• Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease#800503ClinicalTrials.gov
• Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk#807090ClinicalTrials.gov
• Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events#912388ClinicalTrials.gov
• Akershus Cardiac Examination (ACE) 5 Study#995541ClinicalTrials.gov
• Conventional and novel risk scores for cardiovascular disease in Chinese adults#244536Ora Oxford University Research
• Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk#372621Semantic Scholar
• Maternal circadian disruption during pregnancy and offspring diabetic cardiovascular disease risk.#653459NCBI PubMed Central
• CVD Risk Factors and Sexual Identity in Women#992423ClinicalTrials.gov
• Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin#272474ClinicalTrials.gov
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial#850658ClinicalTrials.gov
• Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women#826371ClinicalTrials.gov
• Vascular Lifestyle-Intervention and Screening in Pharmacy#833335ClinicalTrials.gov
• Prevalence of Cardiovascular Risk Factors Among Australian-Lebanese in Melbourne#1026178Victoria University Research Repository (VURR)
• A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event#898328ClinicalTrials.gov
• Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort#218017HAL (France)
• Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health#841564ClinicalTrials.gov
• Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients#826491ClinicalTrials.gov
• Coronary Artery Disease Mechanisms in High Risk Families--Racial Difference#832294ClinicalTrials.gov
• Application for Self-Monitoring of Cardiovascular Risk#890434ClinicalTrials.gov
• Diabetes and glycemic control as predictors of cardiovascular disease risk biomarkers among people with the metabolic syndrome: a longitudinal analysis#627806bioRxiv / medRxiv
• Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina#804297ClinicalTrials.gov
• Study of the Impact of Trans Fatty Acids From Dairy Products on Cardiovascular Risk Factors#862078ClinicalTrials.gov
• Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons#904858ClinicalTrials.gov
• Relationship between cardiovascular parameters and body mass index in perimenopausal women#948084Repositorio de Universidad Autónoma de Chile.
• Validation and Field Test for Risk Appraisal Instruments#851700ClinicalTrials.gov
• Prevalence and clusters of modifiable cardiovascular disease risk factors among intra-city commercial motor vehicle drivers in a Nigerian metropolitan city.#216177University of Ibadan Institutional Repository
• Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality#383811CiNii